Oncolix Inc. wants to help women live longer.
To help accomplish that mission, the biotech firm is developing novel drugs aimed at eradicating women’s cancers such as ovarian and breast cancer.
From the sidelines of the LD Micro conference in Los Angeles, Oncolix CEO Michael Redman tells TheStreet about his company’s approach to developing effective treatments using revolutionary scientific research.
source
